|Bid||2.51 x 0|
|Ask||2.52 x 0|
|Day's range||2.4900 - 2.5900|
|52-week range||2.3100 - 4.2000|
|Beta (3Y monthly)||1.32|
|PE ratio (TTM)||14.02|
|Forward dividend & yield||0.18 (7.14%)|
|1y target est||3.17|
This article is for investors who would like to improve their understanding of price to earnings ratios (P/E ratios). To keep it practical, we'll show how Regis Healthcare Limited's (ASX:REG) Read More...
In June 2018, Regis Healthcare Limited (ASX:REG) released its most recent earnings announcement, which signalled that the company experienced a immense headwind with earnings falling by -12%. Today I want Read More...
Looking at Regis Healthcare Limited’s (ASX:REG) earnings update in June 2018, analyst consensus outlook seem bearish, with profits predicted to drop by -4.9% next year relative to the past 5-year Read More...
Regis Healthcare Limited (ASX:REG), which is in the healthcare business, and is based in Australia, received a lot of attention from a substantial price movement on the ASX over theRead More...
Every investor in Regis Healthcare Limited (ASX:REG) should be aware of the most powerful shareholder groups. Large companies usually have institutions as shareholders, and we usually see insiders owning sharesRead More...
While small-cap stocks, such as Regis Healthcare Limited (ASX:REG) with its market cap of AU$1.01b, are popular for their explosive growth, investors should also be aware of their balance sheetRead More...